SCM
Silverarc Capital Management’s Insmed INSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1M | Sell |
249,060
-72,306
| -22% | -$7.28M | 4.62% | 6 |
|
|
2025
Q1 | $24.5M | Sell |
321,366
-50,864
| -14% | -$3.88M | 5.01% | 5 |
|
|
2024
Q4 | $25.7M | Buy |
372,230
+24,535
| +7% | +$1.69M | 5.62% | 3 |
|
|
2024
Q3 | $25.4M | Buy |
347,695
+207,695
| +148% | +$15.2M | 5.7% | 3 |
|
|
2024
Q2 | $9.38M | Buy |
140,000
+26,384
| +23% | +$1.77M | 2.21% | 12 |
|
|
2024
Q1 | $3.08M | Sell |
113,616
-41,888
| -27% | -$1.14M | 0.86% | 35 |
|
|
2023
Q4 | $4.82M | Buy |
155,504
+5,117
| +3% | +$159K | 1.43% | 31 |
|
|
2023
Q3 | $3.8M | Buy |
150,387
+5,923
| +4% | +$150K | 1.15% | 31 |
|
|
2023
Q2 | $3.05M | Buy |
144,464
+670
| +0.5% | +$14.1K | 0.94% | 32 |
|
|
2023
Q1 | $2.45M | Buy |
143,794
+19,329
| +16% | +$330K | 1.01% | 34 |
|
|
2022
Q4 | $2.49M | Sell |
124,465
-99,551
| -44% | -$1.99M | 0.71% | 42 |
|
|
2022
Q3 | $4.83M | Buy |
224,016
+11,534
| +5% | +$248K | 1.63% | 18 |
|
|
2022
Q2 | $4.19M | Buy |
212,482
+110,415
| +108% | +$2.18M | 1.29% | 17 |
|
|
2022
Q1 | $2.4K | Buy |
102,067
+1,446
| +1% | +$34 | 0.99% | 25 |
|
|
2021
Q4 | $2.74M | Sell |
100,621
-73,967
| -42% | -$2.01M | 1.11% | 28 |
|
|
2021
Q3 | $4.81M | Sell |
174,588
-2,845
| -2% | -$78.3K | 2.72% | 11 |
|
|
2021
Q2 | $5.05K | Sell |
177,433
-13,377
| -7% | -$381 | 2.25% | 10 |
|
|
2021
Q1 | $6.5M | Buy |
190,810
+15,810
| +9% | +$538K | 3.54% | 4 |
|
|
2020
Q4 | $5.83M | Buy |
+175,000
| New | +$5.83M | 3.38% | 4 |
|